Search

Author/Creator Sever, Peter S

3. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Issue 12 (December 2017)

Authors:
Sabatine, Marc S; Leiter, Lawrence A; Wiviott, Stephen D; Giugliano, Robert P; Deedwania, Prakash; De Ferrari, Gaetano M; Murphy, Sabina A; Kuder, Julia F; Gouni-Berthold, Ioanna; Lewis, Basil S; Handelsman, Yehuda; Pineda, Armando Lira; Honarpour, Narimon; Keech, Anthony C; Sever, Peter S; Peder...
Journal:
Lancet
Issue:
Volume 5:Issue 12(2017)
Page Start:
941
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. Issue 10106 (28th October 2017)

Authors:
Giugliano, Robert P; Pedersen, Terje R; Park, Jeong-Gun; De Ferrari, Gaetano M; Gaciong, Zbigniew A; Ceska, Richard; Toth, Kalman; Gouni-Berthold, Ioanna; Lopez-Miranda, Jose; Schiele, François; Mach, François; Ott, Brian R; Kanevsky, Estella; Pineda, Armando Lira; Somaratne, Ransi; Wasserman, Sc...
Journal:
Lancet
Issue:
Volume 390:Issue 10106(2017)
Page Start:
1962
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial. (19th September 2021)

Authors:
Oyama, Kazuma; Giugliano, Robert P; Tang, Minao; Bonaca, Marc P; Saver, Jeffrey L; Murphy, Sabina A; Ruzza, Andrea; Keech, Anthony C; Sever, Peter S; Sabatine, Marc S; Bergmark, Brian A
Journal:
European heart journal
Issue:
Volume 42:Number 47(2021)
Page Start:
4821
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Issue 9984 (6th June 2015)

Authors:
Mega, Jessica L; Stitziel, Nathan O; Smith, J Gustav; Chasman, Daniel I; Caulfield, Mark J; Devlin, James J; Nordio, Francesco; Hyde, Craig L; Cannon, Christopher P; Sacks, Frank M; Poulter, Neil R; Sever, Peter S; Ridker, Paul M; Braunwald, Eugene; Melander, Olle; Kathiresan, Sekar; Sabatine, Ma...
Journal:
Lancet
Issue:
Volume 385:Issue 9984(2015)
Page Start:
2264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Issue 9965 (24th January 2015)

Authors:
Swerdlow, Daniel I; Preiss, David; Kuchenbaecker, Karoline B; Holmes, Michael V; Engmann, Jorgen E L; Shah, Tina; Sofat, Reecha; Stender, Stefan; Johnson, Paul C D; Scott, Robert A; Leusink, Maarten; Verweij, Niek; Sharp, Stephen J; Guo, Yiran; Giambartolomei, Claudia; Chung, Christina; Peasey, A...
Journal:
Lancet
Issue:
Volume 385:Issue 9965(2015)
Page Start:
351
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Issue 4 (18th August 2018)

Authors:
Ferreira, João Pedro; Rossignol, Patrick; Pizard, Anne; Machu, Jean-Loup; Collier, Timothy; Girerd, Nicolas; Huby, Anne-Cécile; Gonzalez, Arantxa; Diez, Javier; López, Begoña; Sattar, Naveed; Cleland, John G; Sever, Peter S; Zannad, Faiez
Journal:
Heart
Issue:
Volume 105:Issue 4(2019)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗